Inari Medical (NARI)
(Real Time Quote from BATS)
$48.19 USD
+1.20 (2.55%)
Updated Jun 28, 2024 02:04 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
NARI 48.19 +1.20(2.55%)
Will NARI be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for NARI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NARI
Here's Why You Should Retain Inari Medical (NARI) for Now
Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?
NARI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Inari Medical (NARI) Sues Truvic on Patent Infringement
Here's Why You Should Retain Inari Medical (NARI) for Now
Other News for NARI
Class Action Lawsuit Against Inari Medical, Inc. (NASDAQ:NARI)
Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)
Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI) and Health Catalyst (HCAT)
Inari Medical: A Strong Buy on Robust 2024 Outlook and Market Expansion Strategies
Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)